Biochem/physiol Actions
Cell permeable: no
Target IC50: 5 nM Inhibiting the expression of inducible but not constitutive nitric oxide synthase in vascular endothelial cells
Reversible: no
Primary TargetPhosphorylation of rb protein
Product does not compete with ATP.
General description
Most active and highly stable glucocorticoid. Inhibits the expression of inducible but not constitutive nitric oxide synthase in vascular endothelial cells (IC50 = 5 nM). Enhances active cation transport in aortic smooth muscle cells by stimulating the Na+-K+ pump. Has anti-inflammatory and antirheumatic properties. Induces apoptosis in human thymocytes. In general, 500-1000 nM of dexamethasone is sufficient to induce apoptosis following a 6 h incubation at 37°C.
Most active and highly stable glucocorticoid. Causes a reduction in cyclin A and Cdk2 activity, and inhibition of G1/S transition in osteoblasts. Inhibits the phosphorylation of retinoblastoma (Rb) protein. Inhibits the expression of inducible but not constitutive nitric oxide synthase in vascular endothelial cells (IC50 = 5 nM). Enhances active cation transport in aortic smooth muscle cells by stimulating the Na+ - K+ pump. Induces apoptosis in human thymocytes.
Legal Information
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
Other Notes
Reil, T.D., et al. 2000. J. Surg. Res.92, 108.Smith, E., et al. 2000. J.Biol. Chem. 275, 1992.Petit, P.X., et al. 1995. J. Cell Biol.130, 157.Stern, N., et al. 1994. Am. J. Hypertens. 7, 146.Donis, J.A., et al. 1993. Biotechniques15, 786.Ohoka, Y., et al. 1993. Biochem. Biophys. Res. Commun.197, 916.Sarin, A., et al. 1993. J. Exp. Med.178, 1693.Vandewalle, A., et al. 1993. J. Cell Physiol.156, 383.Nieto, M.A., et al. 1992. Clin. Exp. Immunol.88, 341.Walsh, D., and Avashia, J. 1992. Cleveland Clin. J. Med. 59, 505.Warters, R.L. 1992. Cancer Res.52, 883.Sperber, K., et al. 1991. J. Allergy Clin. Immunol.87, 490.Radomski, M.W., et al. 1990. Proc. Natl. Acad. Sci. USA 87, 10043.Bettger, W.J., et al. 1981. Proc. Natl. Acad. Sci. USA78, 5588.
Packaging
100 mg in Plastic ampoule
Reconstitution
Following reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 2 months at -20°C.
Warning
Toxicity: Carcinogenic / Teratogenic (D)
This product has met the following criteria to qualify for the following awards: